Welcome to The Reactory:

Dynamic, Scalable Biomanufacturing Less Than An Hour From Kendall Square.

Introducing The Reactory: A Unique Site Specifically Designed To Provide Local Access To Custom-Run And Flexible Biomanufacturing.

As a city with a thriving biotech culture, Worcester’s The Reactory is the ideal place for facilities that specialize in post-R&D scale-up and limited or custom production runs.

With its close proximity to Boston, The Reactory allows R&D teams to monitor and adjust processes in real time in a way that is not possible with more distant facilities. Learn More.

Value Proposition

Thriving Ecosystem Of Biotechnology and Innovation

Accessibility & Infrastructure Of New England’s 2nd Largest City

A Diverse, Highly Skilled Workforce

Low Cost of Doing Business.
High Quality of Life.

MA Biomanufacturing Needs:

82%

Are In Early Stages

Proximity to Manufacturing:

70%

Of Innovative Clinical Programs Are Being Led By Small Companies Where Systems Are Still Evolving And Innovation Is Still Happening

Cost of Living and Doing Business:

22%

Less In Worcester County Than Metro-Boston

Partnerships & Collaborations

Latest News

Worcester Biotech Business Park Lands Financing for Site Preparation

Banker & Tradesman - December 2019
A planned biomanufacturing business park on the grounds of the former Worcester State Hospital is moving forward thanks to financing from Country Bank. The Worcester Business Development Corp. secured a $2.7 million loan from the Ware-based $1.5 billion-asset bank to fund site preparation efforts at The Reactory. The 46-acre complex has eight pads that can accommodate up to 530,000 square feet of development. The WBDC said in a statement.

WuXi Builds Momentum For Worcester Biomanufacturing Park

Worcester Telegram - October 2019
At a meeting on Nov. 13, the board is scheduled to review a site plan for the first building to be constructed on the site: a roughly 110,000-square foot, two-story clinical and commercial research and manufacturing bio-pharmaceutical facility for WuXi Biologics, according to the application before the board. Blais said he and the company are still negotiating a final purchase-and-sale agreement but he hopes the company will begin construction in the spring and create 100 to 150 jobs. He said he anticipates the purchase and sale will be completed in mid-November.